Title : Successful treatment of cystoid macular edema with valdecoxib.

Pub. Date : 2007 Apr

PMID : 17397743






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 PURPOSE: To evaluate the safety and efficacy of the COX-2 inhibitor valdecoxib in treating macular edema after cataract surgery. valdecoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens
2 METHODS: The COX-2 inhibitor valdecoxib (Bextra) was administered systemically to patients with significant visual loss resulting from macular edema in a prospective clinical trial. valdecoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens
3 METHODS: The COX-2 inhibitor valdecoxib (Bextra) was administered systemically to patients with significant visual loss resulting from macular edema in a prospective clinical trial. valdecoxib mitochondrially encoded cytochrome c oxidase II Homo sapiens